Senior Technologist II, Microbiology Laboratory Lahey Hospital & Medical Center, Burlington, MA
BIOGRAPHY
Event Date & Time
Date: December 16, 2020
Time: 7:00am (PST), 10:00am (EST)
Abstract
During this webinar we will discuss the implementation and impact of the MALDI Biotyper® and the MBT Sepsityper® in the clinical microbiology laboratory at Lahey Hospital and Medical Center. We will learn how the implementation of the MBT Sepsityper® rapid sample preparation impacts time-to-result in the identification of organisms directly isolated from positive blood cultures. The components of the MBT Sepsityper® kit will be explained as well as the length of time needed to identify organisms using both rapid and non-rapid sample preparations. Case studies will illustrate the critical time-to-identification for targeted antimicrobial treatment. The webinar will close with a Q & A session.
Learning Objectives
- Learn about the benefits of MALDI-TOF technology over traditional microbiology identification methods
- Understand the difference in workflow and time-to-result between non-rapid and rapid MBT Sepsityper® sample preparation methods
- How can the MBT Sepsityper® solution affect the treatment of a patient, especially after implementing the rapid sample preparation method
*Lahey Hospital and Medical Center have validated all described non-IVD methods, software, kits and workflows for in-house clinical use.
FDA clearance for Bruker´s MBT Sepsityper® Kit US IVD is pending.
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...